Research programme: plasmalogen replacement therapy - Phenomenome Discoveries

Drug Profile

Research programme: plasmalogen replacement therapy - Phenomenome Discoveries

Alternative Names: Ethanolamine plasmalogen precursor - Phenomenome Discoveries; Ether glycerophosphoethanolamine lipid precursor - Phenomenome Discoveries; Ether lipid precursor - Phenomenome Discoveries; PlsEtn precursor - Phenomenome Discoveries; PPI-1011

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Phenomenome Discoveries
  • Class Plasmalogens
  • Mechanism of Action Phospholipid modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Parkinson's disease
  • No development reported Alzheimer's disease; Rhizomelic chondrodysplasia punctata
  • Discontinued Pelizaeus-Merzbacher disease

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in Canada (PO, Capsule)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Rhizomelic-chondrodysplasia-punctata in Canada (PO)
  • 01 Jun 2015 Preclinical trials in Parkinson's disease in Canada (unspecified route) before June 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top